The FDA has accepted for review the BLA for lerodalcibep to reduce LDL-C in patients with or high risk of ASCVD and primary hyperlipidemia.

The FDA has approved Adcetris (brentuximab vedotin) for use in combination with lenalidomide and rituximab to treat patients with relapsed/refractory LBCL after 2 or more lines of systemic therapy who ...

COPD is a progressive lung disease with mild symptoms in the early stages that gradually worsen. Early diagnosis and treatment can help preserve lung function. People with COPD often have trouble ...

The aim of the study was to validate the Norwegian version of a self-administered 43-item questionnaire designed to assess quality of life in kidney transplant recipients, the End-Stage Renal ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with ...

Acute renal failure is caused by damage to the kidneys, which can occur as a result of blood loss, toxins, or physical damage to the kidneys. Acute renal failure occurs rapidly, causing generalized ...

Pharmaceutical company GSK and Oxford University are teaming up to devise a groundbreaking cancer vaccine poised to stop the disease from developing in the first place. The ambition lies in ...

j-hope will become the second member of the record-breaking group to tackle a solo tour, following the footsteps of his bandmate SUGA who completed his “D-DAY Tour” in the spring of 2023. Read on for ...

Microsoft is keen to push 2025 as “the year of the Windows 11 PC refresh.” Yes, this is the year everyone should replace their old Windows 10 PCs with shiny-and-modern Windows 11 PCs ...